+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Pathology Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030

  • PDF Icon

    Report

  • 244 Pages
  • February 2022
  • Region: Global
  • Allied Market Research
  • ID: 5578199
The global digital pathology market was valued at $735.75 million in 2020, and is expected to reach $1791.30 million by 2030, registering a CAGR of 9.3%, registering a CAGR of 9.3% from 2021 to 2030. Digital pathology is a computer-enabled, image-based information platform that helps for the management of information generated from digital slides.. Digital pathology solution offers scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.



The affordable cost of digital pathology products, convenience of virtual slide transportation, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. Furthermore, the market is being driven by an increase in usage of digital pathology solutions as compared to conventional pathology diagnosis. In addition, developing technologies in digital pathology systems, such as digital microscopy, are important tools in surgical pathology. Increase in interest among pathologists for diagnostic, educational and research purposes increases the usage of digital pathology systems in drug discovery. These aforementioned factors have fueled the market growth. On the contrary, high cost associated with digital pathology systems restrains the market growth. However, rise in initiatives toward commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.

According to the data published by Journal of Clinical Medicine, digital pathology is becoming a mainstream option for routine diagnostics. Faster whole slide image scanning is the main way for this development and implementation of new technologies in digital pathology systems. These advantages associated with digital pathology system boost the market growth. In addition, as per the Journal of Pathology, the digital pathology provides greater accuracy and standardization of pathology based trial criteria. The digital pathology platforms improve the training and performance of clinical trial pathologists. Furthermore, increase in number of teleconsultations and rise in adoption of digital pathology systems to enhance lab efficiency drives the growth of the digital pathology market.

According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, around 19.3 million cases of cancer were estimated. According to The World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low & middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of digital pathology market.

In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, and rise in global prevalence of targeted diseases along with surge in geriatric population, are factors that are anticipated to drive the growth of the digital pathology market.

On the contrary, high cost of implementation of digital pathology systems &maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects of radiation emitted from digital pathology systems can lead to cancer as well hinder the growth of the market.

Emerging markets and extensive R&D to build effective digital pathology systems, innovation of various systems, and unmet demand for digital pathology systems in the underdeveloped & developing countries are projected to provide substantial growth opportunities for key players in the digital pathology market.

The digital pathology market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is categorized into scanners, software, and storage & communication systems. On the basis of application, it is classified into teleconsultation, disease diagnosis, drug discovery, and training & education. On the basis of end user, the market is fragmented into educational, clinical, and pharma & biotech companies. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) ,and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Some of the major companies that operate in the global digital pathology market are 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global digital pathology market to identify the prevailing opportunities
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies
  • Comprehensive analysis of factors that drive and restrict the market growth is provided
  • Region- & country-wise analysis is provided to understand the market trends and dynamics

KEY MARKET SEGMENTS


By Product Type

  • Scanners
  • Software
  • Storage & Communication Systems

By Application

  • Teleconsultation
  • Disease Diagnosis
  • Drug Discovery
  • Training & Education

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • 3DHISTECH Ltd
  • Danaher Corporation
  • Glencoe Software Inc
  • HAMAMTSU Photonics KK
  • Indica Labs Inc
  • Koninklijke Philips NV
  • Nikon Corporation
  • Perkinelmer Inc
  • Roche
  • VisoPharma A/S
Frequently Asked Questions about the Global Digital Pathology Market

What is the estimated value of the Global Digital Pathology Market?

The Global Digital Pathology Market was estimated to be valued at $735.75 million in 2020.

What is the growth rate of the Global Digital Pathology Market?

The growth rate of the Global Digital Pathology Market is 9.3%, with an estimated value of $1791.3 million by 2030.

What is the forecasted size of the Global Digital Pathology Market?

The Global Digital Pathology Market is estimated to be worth $1791.3 million by 2030.

Who are the key companies in the Global Digital Pathology Market?

Key companies in the Global Digital Pathology Market include 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche and VisoPharma A/S..

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Porter’S Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Use of Digital Pathology in Disease Diagnosis
3.4.1.2. Increase in Trend of Digitalization in the Medical Sector
3.4.1.3. Ease of Consultation
3.4.1.4. Diagnosis in Remote Regions
3.4.2. Restraints
3.4.2.1. Lack of Reimbursement Policies
3.4.2.2. High Cost of Digital Pathology Solutions
3.4.3. Opportunity
3.4.3.1. Increase in Potential of Digital Pathology
3.4.4. Impact Analyses
Chapter 4: Digital Pathology Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Scanners
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.3. Software
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. Storage and Communication Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
Chapter 5: Digital Pathology Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Teleconsultation
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Disease Diagnosis
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
5.4. Drug Discovery
5.4.1. Market Size and Forecast
5.4.2. Market Analysis, by Country
5.5. Training & Education
5.5.1. Market Size and Forecast
5.5.2. Market Analysis, by Country
Chapter 6: Digital Pathology Market, by End-user
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Educational
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. Clinical
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country
6.4. Pharma & Biotech Companies
6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country
Chapter 7: Digital Pathology Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Market Size & Forecast, by Country
7.2.3. North America Market Size & Forecast, by Product
7.2.4. North America Market Size & Forecast, by Application
7.2.5. North America Market Size & Forecast, by End-user
7.2.6. U. S.
7.2.6.1. U. S. Market Size & Forecast, by Product
7.2.6.2. U. S. Market Size & Forecast, by Application
7.2.6.3. U. S. Market Size & Forecast, by End-user
7.2.7. Canada
7.2.7.1. Canada Market Size & Forecast, by Product
7.2.7.2. Canada Market Size & Forecast, by Application
7.2.7.3. Canada Market Size & Forecast, by End-user
7.2.8. Mexico
7.2.8.1. Mexico Market Size & Forecast, by Product
7.2.8.2. Mexico Market Size & Forecast, by Application
7.2.8.3. Mexico Market Size & Forecast, by End-user
7.3. Europe
7.3.1. Key Trends and Opportunities
7.3.2. Europe Market Size & Forecast, by Country
7.3.3. Europe Market Size & Forecast, by Product
7.3.4. Europe Market Size & Forecast, by Application
7.3.5. Europe Market Size & Forecast, by End-user
7.3.6. Germany
7.3.6.1. Germany Market Size & Forecast, by Product
7.3.6.2. Germany Market Size & Forecast, by Application
7.3.6.3. Germany Market Size & Forecast, by End-user
7.3.7. France
7.3.7.1. France Market Size & Forecast, by Product
7.3.7.2. France Market Size & Forecast, by Application
7.3.7.3. France Market Size & Forecast, by End-user
7.3.8. Uk
7.3.8.1. Uk Market Size & Forecast, by Product
7.3.8.2. Uk Market Size & Forecast, by Application
7.3.8.3. Uk Market Size & Forecast, by End-user
7.3.9. Italy
7.3.9.1. Italy Market Size & Forecast, by Product
7.3.9.2. Italy Market Size & Forecast, by Application
7.3.9.3. Italy Market Size & Forecast, by End-user
7.3.10. Spain
7.3.10.1. Spain Market Size & Forecast, by Product
7.3.10.2. Spain Market Size & Forecast, by Application
7.3.10.3. Spain Market Size & Forecast, by End-user
7.3.11. Rest of Europe
7.3.11.1. Rest of Europe Market Size & Forecast, by Product
7.3.11.2. Rest of Europe Market Size & Forecast, by Application
7.3.11.3. Rest of Europe Market Size & Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Trends and Opportunities
7.4.2. Asia-Pacific Market Size & Forecast, by Country
7.4.3. Asia-Pacific Market Size & Forecast, by Product
7.4.4. Asia-Pacific Market Size & Forecast, by Application
7.4.5. Asia-Pacific Market Size & Forecast, by End-user
7.4.6. Japan
7.4.6.1. Japan Market Size & Forecast, by Product
7.4.6.2. Japan Market Size & Forecast, by Application
7.4.6.3. Japan Market Size & Forecast, by End-user
7.4.7. China
7.4.7.1. China Market Size & Forecast, by Product
7.4.7.2. China Market Size & Forecast, by Application
7.4.7.3. China Market Size & Forecast, by End-user
7.4.8. Australia
7.4.8.1. Australia Market Size & Forecast, by Product
7.4.8.2. Australia Market Size & Forecast, by Application
7.4.8.3. Australia Market Size & Forecast, by End-user
7.4.9. India
7.4.9.1. India Market Size & Forecast, by Product
7.4.9.2. India Market Size & Forecast, by Application
7.4.9.3. India Market Size & Forecast, by End-user
7.4.10. South Korea
7.4.10.1. South Korea Market Size & Forecast, by Product
7.4.10.2. South Korea Market Size & Forecast, by Application
7.4.10.3. South Korea Market Size & Forecast, by End-user
7.4.11. Rest of Asia-Pacific
7.4.11.1. Rest of Asia-Pacific Market Size & Forecast, by Product
7.4.11.2. Rest of Asia-Pacific Market Size & Forecast, by Application
7.4.11.3. Rest of Asia-Pacific Market Size & Forecast, by End-user
7.5. Lamea
7.5.1. Key Trends and Opportunities
7.5.2. Lamea Market Size & Forecast, by Country
7.5.3. Lamea Market Size & Forecast, by Product
7.5.4. Lamea Market Size & Forecast, by Application
7.5.5. Lamea Market Size & Forecast, by End-user
7.5.6. Brazil
7.5.6.1. Brazil Market Size & Forecast, by Product
7.5.6.2. Brazil Market Size & Forecast, by Application
7.5.6.3. Brazil Market Size & Forecast, by End-user
7.5.7. Saudi Arabia
7.5.7.1. Saudi Arabia Market Size & Forecast, by Product
7.5.7.2. Saudi Arabia Market Size & Forecast, by Application
7.5.7.3. Saudi Arabia Market Size & Forecast, by End-user
7.5.8. South Africa
7.5.8.1. South Africa Market Size & Forecast, by Product
7.5.8.2. South Africa Market Size & Forecast, by Application
7.5.8.3. South Africa Market Size & Forecast, by End-user
7.5.9. Rest of LAMEA
7.5.9.1. Rest of LAMEA Market Size & Forecast, by Product
7.5.9.2. Rest of LAMEA Market Size & Forecast, by Application
7.5.9.3. Rest of LAMEA Market Size & Forecast, by End-user
Chapter 8: Competitive Landscape
8.1. Top Player Positioning
8.2. Competitive Dashboard
8.3. Competitive Heatmap
Chapter 9: Company Profiles
9.1.3Dhistech Ltd.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Key Strategic Moves and Developments
9.2. Danaher Corporation (Leica Microsystem)
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Business Performance
9.2.6. Key Strategic Moves and Developments
9.3. Glencoe Software, Inc.
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Hamamatsu Photonics K. K.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Business Performance
9.4.6. Key Strategic Moves and Developments
9.5. Indica Labs Inc.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Key Strategic Moves and Developments
9.6. Koninklijke Philips N. V.
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Business Performance
9.6.6. Key Strategic Moves and Developments
9.7. Nikon Corporation
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.7.5. Business Performance
9.7.6. Key Strategic Moves and Developments
9.8. Perkinelmer Inc.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.8.5. Business Performance
9.9. F- Hoffmann La-Roche (Roche)
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.9.5. Business Performance
9.9.6. Key Strategic Moves and Developments
9.10. Visiopharm A/S
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
9.10.5. Key Strategic Moves and Developments
List of Tables
Table 01. Global Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 02. Digital Pathology Market for Scanners, by Region, 2018–2026 ($Million)
Table 03. Digital Pathology Market for Software, by Region, 2018–2026 ($Million)
Table 04. Digital Pathology Market for Storage and Communication Systems, by Region, 2018–2026 ($Million)
Table 05. Global Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 06. Digital Pathology Market for Teleconsultation, by Region, 2018–2026 ($Million)
Table 07. Digital Pathology Market for Disease Diagnosis, by Region, 2018–2026 ($Million)
Table 08. Digital Pathology Market for Drug Discovery, by Region, 2018–2026 ($Million)
Table 09. Digital Pathology Market for Training & Education, by Region, 2018–2026 ($Million)
Table 10. Global Digital Pathology Market, by End-user, 2019-2026 ($Million)
Table 11. Global Digital Pathology Market for Educational Sector, by Region, 2019-2026 ($Million)
Table 12. Digital Pathology Market for Clinical Sector, by Region, 2019-2026 ($Million)
Table 13. Digital Pathology Market for Pharma & Biotech Companies, by Region, 2019-2026 ($Million)
Table 14. Digital Pathology Market, by Region, 2018–2026 ($Million)
Table 15. North America Digital Pathology Market, by Country, 2018–2026 ($Million)
Table 16. North America Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 17. North America Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 18. North America Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 19. U.S Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 20. U.S Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 21. U.S Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 22. Canada Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 23. Canada Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 24. Canada Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 25. Mexico Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 26. Mexico Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 27. Mexico Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 28. Europe Digital Pathology Market Revenue, by Country, 2018–2026 ($Million)
Table 29. Europe Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 30. Europe Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 31. Europe Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 32. Germany Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 33. Germany Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 34. Germany Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 35. France Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 36. France Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 37. France Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 38. Uk Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 39. Uk Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 40. Uk Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 41. Italy Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 42. Italy Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 43. Italy Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 44. Spain Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 45. Spain Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 46. Spain Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 47. Rest of Europe Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 48. Rest of Europe Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 49. Rest of Europe Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 50. Asia-Pacific Digital Pathology Market Revenue, by Country, 2018–2026 ($Million)
Table 51. Asia-Pacific Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 52. Asia-Pacific Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 53. Asia-Pacific Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 54. Japan Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 55. Japan Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 56. Japan Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 57. China Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 58. China Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 59. China Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 60. Australia Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 61. Australia Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 62. Australia Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 63. India Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 64. India Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 65. India Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 66. South Korea Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 67. South Korea Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 68. South Korea Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 69. Rest of Asia-Pacific Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 70. Rest of Asia-Pacific Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 71. Rest of Asia-Pacific Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 72. Lamea Digital Pathology Market Revenue, by Country, 2018–2026 ($Million)
Table 73. Lamea Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 74. Lamea Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 75. Lamea Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 76. Brazil Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 77. Brazil Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 78. Brazil Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 79. Saudi Arabia Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 80. Saudi Arabia Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 81. Saudi Arabia Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 82. South Africa Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 83. South Africa Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 84. South Africa Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 85. Rest of LAMEA Digital Pathology Market, by Product, 2018–2026 ($Million)
Table 86. Rest of LAMEA Digital Pathology Market, by Application, 2018–2026 ($Million)
Table 87. Rest of LAMEA Digital Pathology Market Revenue, by End-user, 2018–2026 ($Million)
Table 88. 3Dhistech: Company Snapshot
Table 89. 3Dhistech: Product Portfolio
Table 90. Danaher: Company Snapshot
Table 91. Danaher: Operating Segments
Table 92. Danaher: Product Portfolio
Table 93. Glencoe Software: Company Snapshot
Table 94. Glencoe Software: Product Portfolio
Table 95. Hamamatsu: Company Snapshot
Table 96. Hamamatsu: Operating Segments
Table 97. Hamamatsu: Product Portfolio
Table 98. Indica Labs: Company Snapshot
Table 99. Indica Labs: Product Portfolio
Table 100. Philips: Company Snapshot
Table 101. Philips: Operating Segments
Table 102. Philips: Product Portfolio
Table 103. Nikon: Company Snapshot
Table 104. Nikon: Operating Segments
Table 105. Nikon: Product Portfolio
Table 106. Perkinelmer: Company Snapshot
Table 107. Perkinelmer: Operating Segments
Table 108. Perkinelmer: Product Portfolio
Table 109. Roche: Company Snapshot
Table 110. Roche: Operating Segments
Table 111. Roche: Product Portfolio
Table 112. Visiopharm: Company Snapshot
Table 113. Visiopharm: Product Portfolio
List of Figures
Figure 01. Global Digital Pathology Market Segmentation
Figure 02. Top Investment Pockets, 2018
Figure 03. High Bargaining Power of Suppliers
Figure 04. Moderate Bargaining Power of Buyers
Figure 05. High Threat of Substitutes
Figure 06. Moderate Threat of New Entrants
Figure 07. Moderate Competitive Rivalry
Figure 08. Impact Analyses
Figure 09. Comparative Share Analysis of Digital Pathology Market for Scanner, by Country, 2018 & 2026 (%)
Figure 10. Comparative Share Analysis of Digital Pathology Market for Software, by Country, 2018 & 2026 (%)
Figure 11. Comparative Share Analysis of Digital Pathology Market for Storage and Communication Systems, by Country, 2018 & 2026 (%)
Figure 12. Comparative Share Analysis of Digital Pathology Market for Teleconsultation, by Country, 2018 & 2026 (%)
Figure 13. Comparative Share Analysis of Digital Pathology Market for Disease Diagnosis, by Country, 2018 & 2026 (%)
Figure 14. Comparative Share Analysis of Digital Pathology Market for Drug Discovery, by Country, 2018 & 2026 (%)
Figure 15. Comparative Share Analysis of Digital Pathology Market for Training & Education, by Country, 2018 & 2026 (%)
Figure 16. Comparative Share Analysis of Digital Pathology Market for Educational Sector, by Country, 2018 & 2026 (%)
Figure 17. Comparative Share Analysis of Digital Pathology Market for Clinical Sector, by Country, 2018 & 2026 (%)
Figure 18. Comparative Share Analysis of Digital Pathology Market for Pharma & Biotech Companies, by Country, 2018 & 2026 (%)
Figure 19. U. S. Digital Pathology Market, 2018–2026 ($ Million)
Figure 20. Canada Digital Pathology Market, 2018–2026 ($ Million)
Figure 21. Mexico Digital Pathology Market, 2018–2026 ($ Million)
Figure 22. Germany Digital Pathology Market, 2018–2026 ($ Million)
Figure 23. France Digital Pathology Market, 2018–2026 ($ Million)
Figure 24. Uk Digital Pathology Market, 2018–2026 ($ Million)
Figure 25. Italy Digital Pathology Market, 2018–2026 ($ Million)
Figure 26. Spain Digital Pathology Market, 2018–2026 ($ Million)
Figure 27. Rest of Europe Digital Pathology Market, 2018–2026 ($ Million)
Figure 28. Japan Digital Pathology Market, 2018–2026 ($ Million)
Figure 29. China Digital Pathology Market, 2018–2026 ($ Million)
Figure 30. Australia Digital Pathology Market, 2018–2026 ($ Million)
Figure 31. India Digital Pathology Market, 2018–2026 ($ Million)
Figure 32. South Korea Digital Pathology Market, 2018–2026 ($ Million)
Figure 33. Rest of Asia-Pacific Digital Pathology Market, 2018–2026 ($ Million)
Figure 34. Brazil Digital Pathology Market, 2018–2026 ($ Million)
Figure 35. Saudi Arabia Digital Pathology Market, 2018–2026 ($ Million)
Figure 36. South Africa Digital Pathology Market, 2018–2026 ($ Million)
Figure 37. Rest of LAMEA Digital Pathology Market, 2018–2026 ($ Million)
Figure 38. Top Player Positioning, 2018
Figure 39. Competitive Dashboard
Figure 40. Competitive Heatmap of Key Players
Figure 41. Danaher: Net Sales, 2018–2020 ($ Million)
Figure 42. Danaher: Revenue Share by Segment, 2020 (%)
Figure 43. Danaher: Revenue Share by Region, 2020 (%)
Figure 44. Hamamatsu: Net Sales, 2018–2020 ($ Million)
Figure 45. Philips: Net Sales, 2018–2020 ($ Million)
Figure 46. Philips: Revenue Share by Segment, 2020 (%)
Figure 47. Philips: Revenue Share by Region, 2020 (%)
Figure 48. Nikon: Net Sales, 2018–2020 ($ Million)
Figure 49. Nikon: Revenue Share by Segment, 2020 (%)
Figure 50. Nikon: Revenue Share by Region, 2020 (%)
Figure 51. Perkinelmer: Net Sales, 2018–2020 ($ Million)
Figure 52. Perkinelmer: Revenue Share by Segment, 2020 (%)
Figure 53. Perkinelmer: Revenue Share by Region, 2020 (%)
Figure 54. Roche: Net Sales, 2018–2020 ($ Million)
Figure 55. Roche: Revenue Share by Segment, 2020 (%)
Figure 56. Roche: Revenue Share by Region, 2020 (%)

Executive Summary

According to a new report titled, “Digital Pathology Market by Type, Application Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,the digital pathology market was valued at $735.75 million in 2020, and is estimated to reach $1791.30 million by 2030, growing at a CAGR of 9.3% from 2021 to 2030.

Digital pathology is an emerging technology in the field of pathology, where test results are converted into digital images for easy viewing, analysis, storage, and management of the collected data. This is expected to result in many advancements and upgradation of conventional pathology. It introduced whole slide imaging technologies, which enabled the digitalization of an entire specimen at diagnostic quality improves laboratory workflow. Digital pathology is rapidly gaining momentum as an essential technology with specific support for education, drug discovery & tissue based research, and practice of human pathology throughout the world. Thus, lack in number of pathologists globally is addressed by the use of digital pathology, which is the major benefit of this technology. In addition, increase in applications of digital pathology for disease consultation, especially for cancer, boosts the market growth. The other key factors contributing to the growth of this market are rise in prevalence of chronic diseases and convenience in virtual transportation of slides

Increase in prevalence of cancer cases and rise in adoption of new digital pathology systems boost the growth of the market. For instance, in March 2018, F-Hoffmann La-Roche Ltd. announced the launch of VENTANA DP 200 Slide scanner for digital pathology. The scanner is used to produce images with high quality. In addition, in January 2018, Inspirata acquired the company Omnyx from GE healthcare. This acquisition ensured that Inspirata provided one of the most comprehensive digital pathology solutions. Thus, rise in innovations of new digital pathology systems propels the market growth

Furthermore, increase in number of teleconsultations; rise in applications in drug discovery; surge in usage in diagnosis of chronic diseases; increase in use by physicians & scientists for working in various fields such as oncology, medical anatomic pathology, and preclinical toxicology enhance the growth of the market. According to CrownBio Blog, digital pathology is involved in the analysis of tissue samples by trained pathologists. While the work flow of digital pathology is a gold standard for the diagnosis of many diseases which includes cancer. Moreover, implementation of powerful AI technology combined with digital pathology system, and surge the usage in cancer drug discovery drive the growth of the digital pathology market.

Thus, these aforementioned factors are anticipated to drive the growth of the digital pathology market. In addition, initiatives taken by governments to ensure early diagnosis and symptoms of disorders and improvement in development of innovative technologies in the healthcare sector thereby propelling the growth of the market.

On the basis of product type, the scanners segment is expected to register significant growth rate during the forecast period, owing to the benefits offered by digital pathology scanners such as it aids in analyzing multitude of images with ease and in studying complex morphologies & features of soft tissues. In addition, these systems perform repeated data analysis across experiments and produce images with high resolution. Moreover, recent approvals granted by FDA boost the growth of digital pathology scanners market.

On the basis of application, the disease diagnostics segment will show significant growth, owing to growth in number of research activities and increase in adoption of digital scanning among the pharmaceutical and biopharmaceutical companies.

On the basis of end users, the pharma & biotech companies segment accounted for the largest share in the global digital pathology market, as it delivers well-organized, documented, retrieved, and logistical pathological procedures. However, clinical segment will show fastest market growth due to rise in number of clinics incorporating digital pathology over traditional pathology, which in turn ,fuels the market growth.

North America accounted for a majority of the global digital pathology market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic diseases, consumer awareness for early diagnosis, presence of key players, increase in healthcare expenditure, advancements in application, and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in incidences of cancer, surge in demand for healthcare services from an aging population, and increase in investments in healthcare sector in the region.

Key Findings Of The Study


  • On the basis of type, the scanners segment was the highest contributor to the market in 2020
  • On the basis of application type, the disease diagnosis segment dominated the market in 2020, and is expected to continue this trend during the forecast period
  • On the basis of end user, the pharma & biotech companies segment was the highest contributor to the market in 2020
  • On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest 106% CAGR during the forecast period
  • North America dominated the digital pathology market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of cancer, presence of key players, development of the healthcare sector, presence of numerous digital pathology systems, and advancement in technology for digital pathology system in the region Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of inflammatory diseases, improvement in healthcare infrastructure, and technological advancements in digital pathology systems

Companies Mentioned

  • 3DHISTECH LTD
  • Danaher Corporation
  • Glencoe Software Inc.
  • HAMAMTSU Photonics K.K
  • Indica Labs Inc.
  • Koninklijke Philips N.V
  • Nikon Corporation
  • Perkinelmer Inc.
  • Roche
  • VisoPharma A/S.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...